Positive Phase 2 Trial Results from Neuroendocrine Tumor Cohort Presente... ( NEW YORK and MUNICH September 13 2011...)

Positive Phase 2 Trial Results from Neuroendocrine Tumor Cohort Presented at CIRSE

Date:9/13/2011

NEW YORK and MUNICH, September 13, 2011 /PRNewswire/ --

Chemosaturation Demonstrates Clinically Meaningful Tumor Response with Unresectable Neuroendocrine Tumors in the Liver

Delcath Systems, Inc. (NASDAQ: DCTH) announced that updated results from the metastatic neuroendocrine tumor (mNET) cohort of the Company's recently completed Phase 2 clinical trial were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) congress held this week in Munich, Germany. James F. Pingpank, MD, FACS, Associate Professor of Surgery at the University of Pittsburgh School of Medicine and a Principal Investigator of the Phase 2 trial, presented the late-breaking abstract on September 12, 2011at 4:45pm during an Oncologic Intervention oral abstract session.

In the Phase 2 trial's mNET cohort, 24 patients with unresectable mNET in the liver underwent an average of 3 chemosaturation procedures with concentrated melphalan and subsequent extra-corporeal venous hemofiltration. The primary endpoint of overall hepatic response rate (ORR) among the 20 evaluable patients was 70%, including one patient who presented with a confirmed complete response (CR) and 13 with confirmed partial responses (PR). Four patients had stable disease (SD) and 2 progressed at their first evaluation, giving a tumor growth control rate of 90%. As for secondary endpoints, the median overall survival in all 24 patients (on an intent to treat or ITT basis) was reported as 30.4. months. The safety profile of the chemosaturation system was consistent with that previously reported for the Company's Phase 3 melanoma trial.

"Currently available treatment options for patients with unresectable neuroendocrine liver metastases have response rates around 5%. The anti-tumor activity and duration of response seen in the mNET arm of this Phase 2 study is very po
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
2. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
3. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
4. Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontologys 94th Annual Meeting
5. Positive SPA Reply From the FDA for TopoTargets Pivotal Trial With Belinostat in PTCL
6. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
7. Tengion Scientists Publish Positive Preclinical Findings With Neo-Organ Demonstrating Long-term Durability and Growth With Skeletal Maturation
8. InspireMD Announces Enrollment of First Patients in the MGuard(TM) Acute Myocardial Infarction Clinical Trial Data Will be Used to Confirm Initial Positive Results
9. Kuvan Receives Positive Opinion From CHMP for European Approval
10. Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
11. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board

Post Your Comments:

(Date:6/18/2013)... Santa Clara, CA (PRWEB) June 18, 2013 ... compared to standard size SEMs but have limited performance ... and lower resolution. Full size SEMs would normally provide ... require more knowledge to operate and have a higher ... SEMs address the gap between these two types ...

(Date:6/18/2013)... June 17, 2013) A million electric cars could be ... decade with the help of research by the United States ... of Waterloo. , Professor Zhongwei Chen is part of a ... develop non-precious materials to replace the expensive platinum catalysts in ... adoption of fuel cells in vehicles is the cost of ...

(Date:6/18/2013)... China Cord Blood Corporation (NYSE: ... of cord blood collection, laboratory testing, hematopoietic stem cell ... preliminary unaudited financial results for the fourth quarter and ... 2013. Fourth Quarter of Fiscal 2013 ... fiscal 2013 increased by 33.3% to RMB133.0 million ($21.4 ...

(Date:6/18/2013)... 2013 In support of Swiss contributions ... General of Switzerland in New York is pleased to ... Tûranor PlanetSolar , to Manhattan. PlanetSolar is in ... 2013 tour with scientists on board from the University ... runs exclusively on energy from the sun and eliminates ...

[0] Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes [0] US and Canadian researchers drive towards cheaper fuel cells for electric cars [0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City

... an information technology and Web products and services provider ... announced today that St. Luke,s Hospital & Health Network ... remote 24/7/365 IT infrastructure monitoring from CareTech,s Healthcare Infrastructure ... and monitoring of data, systems and applications located in ...

... innovative medical imaging informatics company, today announced the commercial ... Edition. Following the April release of their first commercial ... commercial version of their widely accepted DICOM ImageServer software, ... With the release of the PACS, Team Edition, ...

... windows which, thanks to a nanocoating, adjust their level ... to save energy; novel diagnostic methods and tailor-made nano-medicines ... one hand, can be used to make very efficient ... pheromones, protect vineyards from insect attack; new nanostructured materials ...

Cached Biology Technology:St. Luke's Hospital & Health Network Selects CareTech Solutions to Provide Proactive Monitoring of Hospital IT Infrastructure 2 St. Luke's Hospital & Health Network Selects CareTech Solutions to Provide Proactive Monitoring of Hospital IT Infrastructure 3 ClearCanvas Releases First Commercial Version of Widely Used PACS; Integrated RIS/PACS to Follow 2 A world without nano? Soon hard to imagine 2 A world without nano? Soon hard to imagine 3

St. Luke's Hospital & Health Network Selects CareTech Solutions to Provide Proactive Monitoring of Hospital IT Infrastructure ClearCanvas Releases First Commercial Version of Widely Used PACS; Integrated RIS/PACS to Follow A world without nano? Soon hard to imagine

(Date:6/18/2013)... United Kingdom, the Energy Department,s National Renewable Energy ... recently published a paper describing a novel cellulose-degrading ... quadripunctata , commonly known as the gribble. ... a relatively unique ability to produce their own ... down the biomass they eat. New biomass-degrading enzymes ...

(Date:6/18/2013)... "dead zone" in the Gulf of Mexico and a ... this year, based on several NOAA-supported forecast models. , ... University, and the Louisiana Universities Marine Consortium are ... zone will be between 7,286 and 8,561 square miles ... That would range from an area the size of ...

(Date:6/18/2013)... June 18, 2013 Joshua Obar, Ph.D., Department of ... honored with a 2013 ICAAC Young Investigator Award for ... immunological memory responses to infection. , Obar earned ... 2001 and went on to complete his Ph.D. in ... He performed his Ph.D. thesis research in Edward Usherwood,s ...

Breaking Biology News(10 mins):Novel enzyme from tiny gribble could prove a boon for biofuels research 2 NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2 NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3 NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4 The American Society for Microbiology honors Joshua Obar 2

[0] Novel enzyme from tiny gribble could prove a boon for biofuels research [0] NOAA, partners predict possible record-setting deadzone for Gulf of Mexico [0] The American Society for Microbiology honors Joshua Obar

... that cause the bubonic plague may be more virulent than ... to research published in the May issue of the journal ... order to grow at body temperature. When there is no ... acid called aspartic acid, said Professor Brubaker from the University ...

... embryonic stem cells, said Baylor College of Medicine researchers in ... journal Nature Cell Biology. These findings provide models of ... state, said Dr. Zhou Songyang, professor of biochemistry and molecular ... provides another hint as to how gene transcription is controlled ...

... encounter ethylene, a gas they also produce naturally as a hormone, ... and wilting and fading in the case of flowers all ... growers spray plants with products available in the market today, such ... SM for fruits and vegetables, that contain a compound ...

Cached Biology News:Controlling embryonic fate by association 2 A new idea for how anti-aging products delay ripening of fruit and wilting of flowers 2 A new idea for how anti-aging products delay ripening of fruit and wilting of flowers 3

Scientists discover why plague is so lethal Controlling embryonic fate by association A new idea for how anti-aging products delay ripening of fruit and wilting of flowers

ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....

Rabbit Anti-Mouse Ym1 Polyclonal Antibody,...

ABgene® supplies a 94kDa ultra-pure recombinant thermostable DNA polymerase obtained by high level expression of the Taq DNA polymerase gene in E. coli....

... numbers of samples may be carried out using ... minimum operator attention. System control and data ... CE 4900. The elegant, powerful and very ... and Windows 98 and 2000., The supplied automatic ...

Biology Products:

Taq DNA Polymerase (with KCl buffer) from ABgene Rabbit Anti-Mouse Ym1 Polyclonal Antibody, Unconjugated from StemCell Technologies, Inc.Taq DNA Polymerase (with KCl buffer) from ABgene Adept HPLC System 3, Automatic Isocratic from Cecil Instruments Ltd.